Versant Capital Management, Inc Novo Cure LTD Transaction History
Versant Capital Management, Inc
- $431 Million
- Q3 2024
A detailed history of Versant Capital Management, Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Versant Capital Management, Inc holds 2,461 shares of NVCR stock, worth $40,778. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,461
Previous 3,017
18.43%
Holding current value
$40,778
Previous $51,000
25.49%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding NVCR
# of Institutions
260Shares Held
76.8MCall Options Held
900KPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$201 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$196 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$131 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$71.4 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$50.2 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.74B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...